BridgeBio Pharma, Inc. ($BBIO)
Valantine Hannah โ Director
Shares
10,900
Price
$67.84
Total Value
$739,496.33
Nearby Earnings
Feb 19, 2026
EPS:Est: -0.74
Revenue:Est: $149.07M
Feb 24, 2026
EPS:Est: -0.75
Revenue:Est: $149.07M
Transaction Details
| Insider | Valantine Hannah |
|---|---|
| Title | Director |
| Transaction Date | Feb 27, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 3, 2026 |
| Shares Sold | 10,900 |
| Price per Share | $67.84 |
| Total Value | $739,496.33 |
| Shares Owned After | 7,465 |
| Derivative | No |
| Accession Number | 0001470831-26-000236 |
| Document | View SEC Filing |